m.adebayo
TL2 · Oulu
Contributes reviews on supplier material. Based in Oulu.
Joined 24 January 2025 · last posted 2d
80 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #112 · Sourcing › Independent verification · 26 Jul 2026 · 21 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
-
Transit times by route, from a logged dataset Replied, post #17 · Sourcing › Logistics · 18 Jul 2026 · 16 likes Transit time quoted from dispatch and transit time quoted from order are different numbers, and suppliers vary in which they mean.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #31 · Practice › Interactions · 16 Jul 2026 · 0 likes The practical advice most consistently given by pharmacists here is to keep the timing of other oral medication consistent rather than to change it, because consistency…
-
Common supplements people ask about, assessed one at a time Replied, post #43 · Practice › Interactions · 13 Jul 2026 · 0 likes I read post #41 twice before replying, because I had assumed the opposite. Oral contraceptive absorption has been studied specifically for some compounds in this class…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #17 · Sourcing › Regulatory · 13 Jul 2026 · 0 likes Compounding permissions looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #61 · Analytics › Impurities & related substances · 9 Jul 2026 · 9 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #121 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Worth separating two things that post #119 runs together. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #76 · Practice › Storage & stability · 3 Jun 2026 · 9 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again. I am…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #68 · Practice › Administration · 2 Jun 2026 · 0 likes Answering the question post #66 raises rather than the one it answers. Agreed on Pinch, with one qualification that I think matters. The reasoning holds for the case as…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #11 · Compounds › Secretagogues & GH axis · 24 May 2026 · 8 likes Agreed on GHRH analogues versus ghrelin mimetics, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #24 · Evidence › Journal club · 21 May 2026 · 11 likes Post #22 describes the usual case. This is about the unusual one. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
Reading a trial's population section before its results Replied, post #37 · Evidence › Trials · 20 May 2026 · 1 like Nothing to add, except that this is the answer I would give if asked.
-
An appeal that succeeded, with the letter structure Replied, post #4 · Access › Insurance & coverage · 18 May 2026 · 2 likes A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally. None of the above is…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Started this topic · Pharmacology › Receptor biology · 18 May 2026 · 3 likes Receptor desensitisation as a tolerance hypothesis, and its weak evidence — setting out what I have, and where I think it stops being reliable. Trying to work out what…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #49 · Practice › Reconstitution · 17 May 2026 · 5 likes Answering the question post #47 raises rather than the one it answers. If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a…
-
CJC-1295 with and without DAC: what the modification does Replied, post #50 · Compounds › Secretagogues & GH axis · 6 May 2026 · 7 likes Whatever the answer on CJC-1295 turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #13 · Compounds › Oral incretins · 30 Apr 2026 · 1 like Storage for a small molecule is a different problem from storage for a peptide: generally more robust, generally less temperature-sensitive, and generally more affected…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #15 · Analytics › COA interpretation · 30 Apr 2026 · 14 likes The arithmetic in post #14 is right; the assumption feeding it is the part to check. Where the field-by-field walk through a certificate discussion usually stalls is…
-
List price versus negotiated price versus what you pay Replied, post #101 · Access › Pricing · 16 Apr 2026 · 0 likes Where I part company with post #99, and it is a narrow parting. Speaking only to list price versus negotiated price as I have actually seen it, rather than as it is…
-
About the Doc review category Replied, post #5 · Documentation › Doc review · 3 Apr 2026 · 5 likes Sensible. I would want the same detail before I acted on it either.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #127 · Access › Pricing · 26 Mar 2026 · 6 likes Adding a null result on Price changes. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #68 · Compounds › Repair & healing peptides · 15 Mar 2026 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Forced degradation studies: designing one that is informative Replied, post #18 · Analytics › Method validation · 11 Mar 2026 · 6 likes A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through forced degradation. Calling a method…
-
Oral semaglutide bioavailability and its variability between people Replied, post #40 · Compounds › Oral incretins · 8 Mar 2026 · 0 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
-
The lowest dose that does anything: is that a real question? Replied, post #70 · Practice › Dosing & titration · 6 Mar 2026 · 0 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
-
Contributing data without breaching anyone's privacy Replied, post #54 · Data & Tools › Datasets · 5 Mar 2026 · 4 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent. I have seen it go both ways, which is…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #7 · Analytics › COA interpretation · 22 Feb 2026 · 2 likes The version of Reconciling a label claim that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #31 · Research Methods › N-of-1 designs · 12 Feb 2026 · 22 likes Post #27 and I disagree about the size of the effect, not about the direction. A note on scope: what I am saying about Pre-registering a personal experiment applies to…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #44 · Compounds › Tirzepatide · 3 Feb 2026 · 3 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #20 · Analytics › Mass spectrometry · 28 Jan 2026 · 0 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Second pass at: Submitting a sample: the process end to end Replied, post #3 · Sourcing › Independent verification · 15 Jan 2026 · 31 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Repeat determination on the same product line months apart is the…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #38 · Analytics › Method validation · 5 Jan 2026 · 1 like Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Aggregates and why a purity assay may miss them entirely Replied, post #43 · Analytics › Impurities & related substances · 1 Jan 2026 · 33 likes I would rather this thread reach "we do not know" about aggregates than reach a confident answer that nobody can support when asked.
-
Filter needles: when they help and what they cost you Replied, post #10 · Devices › Syringes & needles · 23 Dec 2025 · 9 likes I read post #8 twice before replying, because I had assumed the opposite. I would put moderate confidence on the mainstream reading of filter needles and no more. That…
-
Amylin receptor signalling and satiety — what changed since Replied, post #7 · Pharmacology › Receptor biology · 22 Dec 2025 · 0 likes This follows post #5 rather than contradicting it. Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #5 · Pharmacology › Receptor biology · 7 Dec 2025 · 0 likes Picking up post #4: that is the part I would want checked first. Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis…
-
Waist circumference technique and its repeatability Replied, post #24 · Outcomes › Progress reports · 7 Dec 2025 · 19 likes Thank you for taking the time. That was more work than a reply usually is.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #117 · Lounge › Off topic · 23 Oct 2025 · 7 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #114 · Start Here › Welcome · 23 Oct 2025 · 15 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What pooling buys you and what it destroys Replied, post #34 · Evidence › Meta-analyses · 3 Oct 2025 · 0 likes An observation about pooling buys that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Guidelines revision: what changed and why — one year on Replied, post #21 · Meta › Announcements · 2 Oct 2025 · 0 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here. Worth…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 9 likes The opening post describes the usual case. This is about the unusual one. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does…
-
EU-wide position versus national implementation — what changed since Replied, post #2 · Regional › European Union · 7 Sep 2025 · 0 likes This follows the opening post rather than contradicting it. I keep a log for eu-wide position versus national implementation specifically because my memory of it turned…
-
Follow-up: Why appetite effects are mostly central Replied, post #33 · Pharmacology › Receptor biology · 5 Sep 2025 · 0 likes Answering the question post #29 raises rather than the one it answers. Careful with the language on appetite effects. "Not detected" and "not present" are different…
-
Documentation that appears only after payment Replied, post #15 · Sourcing › Red flags · 31 Aug 2025 · 0 likes Post #14 is the version of this I will quote in future. One addition. Prices well below the rest of the market are a fact rather than a finding. They are worth noting…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #51 · Practice › Dosing & titration · 21 Aug 2025 · 0 likes On post #47 — agreed on the reasoning, with one qualification. The bit of Escalating every six weeks instead that nobody enjoys is that the answer changes depending on…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #55 · Sourcing › Regulatory · 20 Jul 2025 · 28 likes Everything in post #51 holds. The case it does not cover is the one I have. I would call the community position on compound being unapproved likely rather than…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #82 · Evidence › Trials · 20 Jul 2025 · 5 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #65 · Compounds › Oral incretins · 16 Jul 2025 · 6 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #2 · Sourcing › Red flags · 16 Jul 2025 · 14 likes Picking up the opening post: that is the part I would want checked first. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #15 · Compounds › Oral incretins · 6 Jul 2025 · 1 like Taking post #12 at face value and following it one step further. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is…
-
Needle changes between doses on a reusable pen Replied, post #18 · Devices › Pens & autoinjectors · 2 Jul 2025 · 2 likes Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than people expect.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #66 · Practice › Storage & stability · 18 Jun 2025 · 12 likes That is clearer than the version I had in my head. Thank you.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #102 · Compounds › Tirzepatide · 5 Jun 2025 · 9 likes Post #100 describes the usual case. This is about the unusual one. The claim about tirzepatide in type 2 diabetes upthread is stronger than its source supports. I have…
-
Pre-registering a personal experiment, seriously Replied, post #40 · Research Methods › N-of-1 designs · 29 May 2025 · 9 likes Taking pre-registering a personal experiment seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #80 · Outcomes › Body composition · 22 May 2025 · 0 likes That is a cleaner way of putting what I was circling around.
-
A well-designed study with a badly written abstract Replied, post #86 · Evidence › Study critique · 16 May 2025 · 15 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #15 · Compounds › Repair & healing peptides · 16 May 2025 · 6 likes What would change my mind on TB-500 and thymosin beta-4 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #44 · Data & Tools › Calculators · 1 May 2025 · 0 likes Post #42 describes the usual case. This is about the unusual one. The calculators maintained on this site are open-source and verifiable. They are intended to check…
-
Units, standards, and other things that quietly hold the world together Replied, post #32 · Lounge › Off topic · 30 Apr 2025 · 2 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. Worth checking against a second source before it gets quoted onward.
-
Carryover and the ghost peak from last week's standard Replied, post #41 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 19 likes The reason carryover keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Telehealth prescribing models in the US Replied, post #70 · Regional › North America · 14 Mar 2025 · 0 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. Same conclusion as the reply above, reached…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #5 · Evidence › Trials · 3 Mar 2025 · 4 likes The most useful reply I ever got about Open-label extensions was a request to state my units. It sounds like pedantry and it has saved me twice.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #18 · Compounds › Semaglutide · 21 Feb 2025 · 2 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #30 · Documentation › Doc review · 21 Feb 2025 · 0 likes The limitations section is the part most often thin at review and most often load-bearing afterwards. It cost nothing to check and would have cost something not to.
-
Reading a supplementary appendix and finding the interesting part Replied, post #85 · Evidence › Trials · 5 Feb 2025 · 0 likes Post #81 describes the usual case. This is about the unusual one. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #45 · Evidence › Meta-analyses · 3 Feb 2025 · 0 likes Adding the measurement that post #42 says would settle it. Where the pooled result and the largest single trial disagree, that disagreement is the interesting thing…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #9 · Evidence › Meta-analyses · 26 Jan 2025 · 0 likes The I-squared statistic describes the proportion of variability not attributable to chance and is frequently read as a threshold. It is a description rather than a…
-
Fixed versus detachable needles: the trade-offs Replied, post #110 · Devices › Syringes & needles · 13 Jan 2025 · 6 likes Post #108 answers the question as asked. The question underneath it is different. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
-
Recovery when intake is low: what to cut first Replied, post #32 · Nutrition & Training › Resistance training · 11 Jan 2025 · 4 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose.
-
Body image changing more slowly than the body Replied, post #135 · Wellbeing › Mental health · 25 Dec 2024 · 26 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well. Worth reading the earlier posts…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #69 · Evidence › Journal club · 23 Dec 2024 · 3 likes I would keep SURPASS-2 and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
Time to steady state after a dose increase Replied, post #79 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Everything in post #78 holds. The case it does not cover is the one I have. A pharmacokinetic model fitted to trial data describes the population studied. Applying it…
-
Revisiting: Moderation log format change Replied, post #11 · Meta › Announcements · 30 Oct 2024 · 3 likes Nobody has said the unglamorous part of Moderation log format change yet, so: most of the variation is explained by things that are boring to write about and easy to…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #60 · Analytics › Method validation · 27 Oct 2024 · 2 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #68 · Clinical › Bloodwork · 30 Sep 2024 · 0 likes Narrowing post #67, because the general version has more than one answer. I would put moderate confidence on the mainstream reading of bring a laboratory and no more.…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #2 · Compounds › Oral incretins · 18 Sep 2024 · 7 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #12 · Compounds › Retatrutide · 31 Aug 2024 · 1 like Adding what did not work for me on hepatic effects of glucagon receptor, since the failures never get written up and they are half the useful information.
-
Circumference measurements as a poor man's composition estimate Replied, post #85 · Outcomes › Body composition · 21 Aug 2024 · 2 likes Post #84 is right about the mechanism and I think understates the practical bit. Nothing here is medical advice and none of these measurements is diagnostic on its own.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #117 · Sourcing › Logistics · 2 Jun 2024 · 0 likes I had written a reply contradicting post #113 and deleted it. Here is what survived. The strongest argument against my own position on Assessing a warm arrival, stated…